Featured Research

from universities, journals, and other organizations

Innate cells shown to form immunological 'memory' and protect against viral infection

Date:
August 5, 2011
Source:
Public Library of Science
Summary:
Researchers have demonstrated that cells of the innate immune system are capable of "memory", and of mounting rapid protection to an otherwise lethal dose of live vaccinia virus. The study challenges previous thought that only B cells and T cells can store memory to ward off future infection. The finding has potentially significant consequences for the design of future vaccines, particularly for HIV.

Researchers have demonstrated that cells of the innate immune system are capable of "memory," and of mounting rapid protection to an otherwise lethal dose of live vaccinia virus. The study, published in the Open Access journal PLoS Pathogens on August 4th, challenges previous thought that only B cells and T cells can store memory to ward off future infection.

The finding, by researchers from Beth Israel Deaconess Medical Center, Harvard Medical School, and Hebrew University and Duke University, has potentially significant consequences for the design of future vaccines, particularly for HIV.

Immunological "memory" is what the immune system builds to respond more effectively to pathogens (such as bacteria and viruses) that the host organism has encountered previously. Traditionally, immunological "memory" has been thought to reside within the cells of the adaptive arm of the immune system (B cells and T cells) that recognize highly specific portions of pathogens through unique receptors.

This study, lead by Dr. Geoffrey Gillard, shows that an innate population of cells, called natural killer (NK) cells form "memory" to vaccinia virus infection despite the fact that they lack the receptors of traditional "memory" cells. Transfer of "memory" NK cells into immunodeficient mice was enough to protect these mice against a normally lethal exposure to vaccinia virus. Because the NK cell population lacks the receptors that allow B and T cells to develop highly specific "memory" responses to pathogens, the study raises important questions to the manner in which "memory" NK cells are capable of recognizing virus upon a second exposure.

Understanding how innate "memory" functions will be critical for incorporating this property into more effective vaccines, particularly as part of a vaccine against HIV. The properties of NK memory, most notably the ability to respond very rapidly, may be helpful in exerting early control of HIV infection by limiting the ability of the virus to overwhelm the host immune system in the early stages of infection.


Story Source:

The above story is based on materials provided by Public Library of Science. Note: Materials may be edited for content and length.


Journal Reference:

  1. Geoffrey O. Gillard, Maytal Bivas-Benita, Avi-Hai Hovav, Lauren E. Grandpre, Michael W. Panas, Michael S. Seaman, Barton F. Haynes, Norman L. Letvin. Thy1 Nk Cells from Vaccinia Virus-Primed Mice Confer Protection against Vaccinia Virus Challenge in the Absence of Adaptive Lymphocytes. PLoS Pathogens, 2011; 7 (8): e1002141 DOI: 10.1371/journal.ppat.1002141

Cite This Page:

Public Library of Science. "Innate cells shown to form immunological 'memory' and protect against viral infection." ScienceDaily. ScienceDaily, 5 August 2011. <www.sciencedaily.com/releases/2011/08/110804180306.htm>.
Public Library of Science. (2011, August 5). Innate cells shown to form immunological 'memory' and protect against viral infection. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2011/08/110804180306.htm
Public Library of Science. "Innate cells shown to form immunological 'memory' and protect against viral infection." ScienceDaily. www.sciencedaily.com/releases/2011/08/110804180306.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com
$23.6 Billion Awarded To Widow In Smoking Lawsuit

$23.6 Billion Awarded To Widow In Smoking Lawsuit

Newsy (July 20, 2014) Cynthia Robinson claims R.J. Reynolds Tobacco Company hid the health and addiction risks of its products, leading to the death of her husband in 1996. Video provided by Newsy
Powered by NewsLook.com
Tooth Plaque Provides Insight Into Diets Of Ancient People

Tooth Plaque Provides Insight Into Diets Of Ancient People

Newsy (July 19, 2014) Research on plaque from ancient teeth shows that our prehistoric ancestor's had a detailed understanding of plants long before developing agriculture. Video provided by Newsy
Powered by NewsLook.com
Contaminated Water Kills 3 Babies in South African Town

Contaminated Water Kills 3 Babies in South African Town

AFP (July 18, 2014) Contaminated water in South Africa's northwestern town of Bloemhof kills three babies and hospitalises over 500 people. The incident highlights growing fears over water safety in South Africa. Duration: 02:22 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins